- Competing Budget Policy Statement
The National Cancer Institute is targeting unfunded competing research project grant applications submitted for funding in the usual
cycle of Fiscal Year 2009. As a rule, grants paid on the ARRA funding plan will receive two years of support.
The following paylines are extensions of the regular paylines described at: http://deainfo.nci.nih.gov/grantspolicies/FinalFundLtr.htm
- Competing New (Type 1) and Continuation (Type 2) Traditional R01s
The first two years of Type-1 and Type-2 R01 applications up to the 25.0 percentile will be paid. Non-percentiled R01s will be paid on a case by case basis. In addition to the two years of ARRA support, selected grants will receive an additional two-year commitment of support from NCI appropriated funds.
- New Exploratory Development (Type 1) R21 up to the 25.0 percentile will be paid.
- New Small grants (Type 1) R03s up to priority score 225 will be paid.
- New AREA (Type 1) R15s up to priority score 200 will be paid.
- Program Project (P01) Applications (new and competing continuations): Additional P01s will be paid on a case by case basis. P01 applicants will be notified of their potential for funding by the NCI program staff..
- Large Dollar Amount Percentiled R01s: This payline has not yet been established.
- Competing R01 Applications from First-time R01 Investigators
NCI has a strong commitment to first-time R01 awardees. Therefore, applicants eligible for consideration as first-time R01 investigators up to the 25.0 percentile will receive the two years of ARRA support plus an additional three-year commitment of support from NCI appropriated funds.
- Policy Reductions (all mechanisms)
Competing Research Project Grant awards funded with the American Recovery and Reinvestment Act (ARRA) will follow budget reduction policies established for grants awarded under the regular FY 2009 appropriation.
